ClearPoint Neuro

Q3 FY2026 EarningsQ3 FY26 results presented a slight revenue miss and a notable EPS beat. Total revenue of $12.1M grew 36% YoY but fell just short of the $12.3M consensus. However, GAAP EPS of -$0.24 significantly outperformed the -$0.32 consensus, driven by disciplined expense management despite a margin contraction to 58% (vs. 60.35% expected). Neurosurgery navigation grew 59% YoY, fueled by the IRRAflow acquisition, while management tightened FY26 revenue guidance to $48.0M-$50.0M, maintaining the mid-point relative to prior expectations.